BH, N., MI, A., NNN, A., HJ, L., CI, S., MFM, J., . . . AYL, B. (2024). The outcome of 12-week corticosteroid therapy in COVID-19-related diffuse interstitial lung abnormalities. The Medical journal of Malaysia, 79(3), 296.
Chicago Style (17th ed.) CitationBH, Ng, et al. "The Outcome of 12-week Corticosteroid Therapy in COVID-19-related Diffuse Interstitial Lung Abnormalities." The Medical Journal of Malaysia 79, no. 3 (2024): 296.
MLA (9th ed.) CitationBH, Ng, et al. "The Outcome of 12-week Corticosteroid Therapy in COVID-19-related Diffuse Interstitial Lung Abnormalities." The Medical Journal of Malaysia, vol. 79, no. 3, 2024, p. 296.
Warning: These citations may not always be 100% accurate.
